Basic info
Industry
biotechnology research
Sectors
Biotechnology
Innovation
Respiratory infection
MEK inhibitors
Influenza
Therapeutics
Antivirals
Science
Pharmaceutical
Biopharma
Viral infection
Date founded
2015
Funding rounds raised
Total raised
$10M
from 5 investors over 5 rounds
A
Atriva Therapeutics GmbH raised $10M on August 12, 2020
Investors: Meneldor and High-Tech Gründerfonds
A
Atriva Therapeutics GmbH raised undisclosed on January 3, 2019
Investors: High-Tech Gründerfonds and Meneldor
A
Atriva Therapeutics GmbH raised undisclosed on February 7, 2017
Investors: High-Tech Gründerfonds